Biofund Logo
Login

News

Surgalign Holdings, Inc. Expands Digital Health Capabilities with Acquisition of a Significant Equity Interest in Inteneural Networks Inc.

Surgalign Holdings, Inc. Expands Digital Health Capabilities with Acquisition of a Significant Equity Interest in Inteneural Networks Inc.

Artificial Intelligence Technology Will Enable Computers to Autonomously Identify and Segment Neural Structures in Medical Images and Provide Reference Information Regarding Pathological States.

Oct 23, 2020

Dystrogene Gene Therapy Shows Promise for Huntington’s

Dystrogene Gene Therapy Shows Promise for Huntington’s

DYST 201, a gene therapy targeting the mutated forms of the gene responsible for Huntington’s disease, has shown promising results, Dystrogen Therapeutics announced.

Apr 16, 2019

HoloSurgical Inc, a Digital Surgery Company, Announces First Surgical Procedure Utilizing the ARAI™, an Augmented Reality and Artificial Intelligence Based Surgical Navigation System

HoloSurgical Inc, a Digital Surgery Company, Announces First Surgical Procedure Utilizing the ARAI™, an Augmented Reality and Artificial Intelligence Based Surgical Navigation System

The ARAI™ is an advanced digital surgery platform that combines 3D visualization, data analytics, and machine learning to improve outcomes, reduce surgical time, and decrease surgical complications. The clinically-tested ARAI™ surgical guidance system provides real-time, patient-specific, 3D anatomical visualization for…

Jan 9, 2019

1 2 3
CONTACT

Get in Touch

Interested in learning more about our portfolioor investment opportunities?

info@biofound.us